IN2015DN00138A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00138A IN2015DN00138A IN138DEN2015A IN2015DN00138A IN 2015DN00138 A IN2015DN00138 A IN 2015DN00138A IN 138DEN2015 A IN138DEN2015 A IN 138DEN2015A IN 2015DN00138 A IN2015DN00138 A IN 2015DN00138A
- Authority
- IN
- India
- Prior art keywords
- library
- human germline
- antibody chains
- germline antibody
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695819P | 2012-08-31 | 2012-08-31 | |
| PCT/EP2013/068110 WO2014033304A2 (fr) | 2012-08-31 | 2013-09-02 | Banques d'anticorps combinatoires hautement divers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00138A true IN2015DN00138A (fr) | 2015-06-12 |
Family
ID=49117845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN138DEN2015 IN2015DN00138A (fr) | 2012-08-31 | 2013-09-02 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10040870B2 (fr) |
| EP (1) | EP2890709A2 (fr) |
| JP (1) | JP6283030B2 (fr) |
| CN (1) | CN104583236A (fr) |
| AU (1) | AU2013310839B2 (fr) |
| CA (1) | CA2879834A1 (fr) |
| IL (1) | IL236524B (fr) |
| IN (1) | IN2015DN00138A (fr) |
| WO (1) | WO2014033304A2 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3297672B1 (fr) | 2015-05-21 | 2021-09-01 | Harpoon Therapeutics, Inc. | Protéines trispécifiques de liaison et méthodes d'utilisation |
| AU2017267793B2 (en) | 2016-05-20 | 2024-01-25 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| JP7101621B2 (ja) | 2016-05-20 | 2022-07-15 | ハープーン セラピューティクス，インク． | 単一ドメイン血清アルブミン結合タンパク質 |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| KR20190039937A (ko) | 2016-07-08 | 2019-04-16 | 스태튼 바이오테크놀로지 비.브이. | 항-ApoC3 항체 및 이의 사용 방법 |
| US10844134B2 (en) | 2016-11-23 | 2020-11-24 | Harpoon Therapeutics, Inc. | PSMA targeting trispecific proteins and methods of use |
| CN110198955A (zh) | 2016-11-23 | 2019-09-03 | 哈普恩治疗公司 | 前列腺特异性膜抗原结合蛋白质 |
| CN110139952B (zh) * | 2016-12-09 | 2022-11-25 | 深圳华大生命科学研究院 | 骆驼科抗体可变区免疫组库构建的引物组合及应用 |
| EP3589662A4 (fr) | 2017-02-28 | 2020-12-30 | Harpoon Therapeutics, Inc. | Protéine monovalente inductible de fixation d' antigène |
| AU2018255938A1 (en) | 2017-04-21 | 2019-10-31 | Staten Biotechnology B.V. | Anti-ApoC3 antibodies and methods of use thereof |
| CA3063362A1 (fr) | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Proteines trispecifiques ciblant la msln et procedes d'utilisation |
| AU2018265856B2 (en) | 2017-05-12 | 2023-04-27 | Harpoon Therapeutics, Inc. | Mesothelin binding proteins |
| SG11202003341UA (en) | 2017-10-13 | 2020-05-28 | Harpoon Therapeutics Inc | B cell maturation antigen binding proteins |
| CR20200196A (es) | 2017-10-13 | 2020-06-05 | Harpoon Therapeutics Inc | Proteínas trispecìficas y mètodos de uso |
| US10538583B2 (en) | 2017-10-31 | 2020-01-21 | Staten Biotechnology B.V. | Anti-APOC3 antibodies and compositions thereof |
| CN111315772A (zh) | 2017-10-31 | 2020-06-19 | 斯塔顿生物技术有限公司 | 抗apoc3抗体及其使用方法 |
| US10815311B2 (en) | 2018-09-25 | 2020-10-27 | Harpoon Therapeutics, Inc. | DLL3 binding proteins and methods of use |
| JP2023527609A (ja) | 2020-02-21 | 2023-06-30 | ハープーン セラピューティクス，インク． | Ｆｌｔ３結合タンパク質および使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| GB2461546B (en) * | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| US8444976B2 (en) * | 2008-07-02 | 2013-05-21 | Argen-X B.V. | Antigen binding polypeptides |
| CA2762837C (fr) * | 2009-05-20 | 2021-08-03 | Novimmune S.A. | Banques de polypeptides synthetiques et procedes de creation de variants polypeptidiques naturellement diversifies |
| GB2476681B (en) | 2010-01-04 | 2012-04-04 | Argen X Bv | Humanized camelid VH, VK and VL immunoglobulin domains |
-
2013
- 2013-09-02 US US14/419,881 patent/US10040870B2/en active Active
- 2013-09-02 EP EP13758830.7A patent/EP2890709A2/fr not_active Withdrawn
- 2013-09-02 JP JP2015529046A patent/JP6283030B2/ja active Active
- 2013-09-02 WO PCT/EP2013/068110 patent/WO2014033304A2/fr active Application Filing
- 2013-09-02 IN IN138DEN2015 patent/IN2015DN00138A/en unknown
- 2013-09-02 CN CN201380044638.9A patent/CN104583236A/zh active Pending
- 2013-09-02 AU AU2013310839A patent/AU2013310839B2/en active Active
- 2013-09-02 CA CA2879834A patent/CA2879834A1/fr not_active Abandoned
-
2014
- 2014-12-31 IL IL236524A patent/IL236524B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014033304A3 (fr) | 2014-05-01 |
| AU2013310839A1 (en) | 2015-01-29 |
| CA2879834A1 (fr) | 2014-03-06 |
| EP2890709A2 (fr) | 2015-07-08 |
| US20150166680A1 (en) | 2015-06-18 |
| JP6283030B2 (ja) | 2018-02-21 |
| IL236524A0 (en) | 2015-02-26 |
| CN104583236A (zh) | 2015-04-29 |
| IL236524B (en) | 2019-01-31 |
| US10040870B2 (en) | 2018-08-07 |
| JP2015526495A (ja) | 2015-09-10 |
| WO2014033304A2 (fr) | 2014-03-06 |
| AU2013310839B2 (en) | 2017-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN00138A (fr) | ||
| IN2014DN08163A (fr) | ||
| MX2021003704A (es) | Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales. | |
| PH12016500823A1 (en) | Production of t cell retargeting hetero-dimeric immunoglobulins | |
| PH12015502293A1 (en) | Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use | |
| MY178142A (en) | Anti-phf-tau antibodies and their uses | |
| SG194466A1 (en) | Non-human animals expressing antibodies having a common light chain | |
| PH12018501611A1 (en) | Antigen binding proteins thant bind pd-l1 | |
| EP3388449A3 (fr) | Anticorps et conjugués modifies génetiquement avec de la cystéine | |
| EA201790043A1 (ru) | Наноносители, вырабатывающие иммунную толерантность, для вырабатывания cd8+ регуляторных т-клеток | |
| NZ629296A (en) | Humanized antibodies that recognize alpha-synuclein | |
| WO2013041845A3 (fr) | Animaux, répertoires & procédés | |
| MX2015012540A (es) | Ratón de cadena ligera común. | |
| IN2014CN03572A (fr) | ||
| MX352338B (es) | Anticuerpos neutralizantes del virus de la influenza a y usos de estos. | |
| EA201890942A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
| EA201591113A1 (ru) | Антитела против антигена 2 дендритных клеток крови и их применение | |
| NZ705606A (en) | Methods for identifying antibodies with reduced immunogenicity | |
| UY34343A (es) | Proteinas de unión al antígeno cd27l | |
| IL241433A0 (en) | A protocol for identifying and isolating antigens specific to b cells and creating antibodies to desired antigens | |
| MX346500B (es) | Metodos y composiciones para inmunoterapia para enfermedad neural. | |
| NZ703973A (en) | Complex chromosome engineering for production of human antibodies in transgenic animals | |
| NZ729747A (en) | Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same | |
| MX2015010428A (es) | Anticuerpos anti-her2 altamente galactosilados y sus usos. | |
| EA201400447A1 (ru) | АНТИТЕЛА К CD1d |